Publication dates

Biogen Idec Industry, October 2014 Market Research & Statistics

You might be interested in: drug, water, medication, more »

1-10 of about 500 reports for Biogen Idec

Download Unlimited Documents from Trusted Public Sources

Global Drug Demand Forecast

  • Orphan Drug Report 2013
  • January 2013
    19 pages
  • Drug  

  • World  

    Europe  

    United States  

View report >

Pharmaceutical Markets in the US - Forecast

  • Pharma Outlook
  • January 2013
    42 pages
  • Pharmaceutical  

  • United States  

    Europe  

View report >

Pharmaceutical Markets in the US - Forecast

  • Pharma Outlook
  • January 2013
    40 pages
  • Pharmaceutical  

  • United States  

    Europe  

View report >

Analyst Report, July 2014

  • Morning News call
  • July 2014
    6 pages
  • United States  

    China  

View report >

Drug Industry in China

  • Orphan Drugs - Sourcing Api from Emerging Markets
  • August 2014
    7 pages
  • Drug  

  • China  

View report >

Global Prescription Drug Markets - Forecast

  • World Preview 2014, Outlook to 2020
  • January 2014
    39 pages
  • Prescription Dr...  

    Prescription Dr...  

  • World  

    United States  

    Japan  

View report >

Healthcare Industry in Asia - Forecast

  • April 2014
    12 pages
  • Healthcare  

  • China  

    Asia  

    United States  

View report >

Global Drug Markets - Forecast

  • Orphan Drug Report 2013
  • January 2013
    19 pages
  • Drug  

  • World  

    United States  

    Europe  

View report >

Medication Sales Demand in the US - Forecast

  • New Drug Pipeline
  • January 2013
    8 pages
  • Medication  

  • United States  

View report >

Investment Banking Statistics in the US

  • Statement of Investments
  • September 2013
    4 pages
  • Investment Bank...  

  • United States  

View report >
About 300 reports for Biogen Idec

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 10 995)

KOL Insight: Multiple Sclerosis

KOL Insight: Multiple Sclerosis

  • $ 6 495
  • Industry report
  • October 2014
  • by Firstword Pharma

Recent launches of oral therapies have brought clinical advantages and clear patient benefits and are set to transform the treatment of Multiple Sclerosis (MS). The question is, which products will rise ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.